News
News
- Shire Announces FDA Approval for Label Expansion of CINRYZE® for Prevention of Attacks in Pediatric HAE
06/21/2018 / 08:00 - GlobeNewswire - BioCryst Announces Presentation of Additional Analyses of the APeX-1 Clinical Trial of BCX7353 at the 2018 European Academy of Allergy and Clinical Immunology (EAACI) Congress
05/29/2018 / 14:00 - GlobeNewswire - RWE revenue falls 7.3% to €11.6B in Q1
05/15/2018 / 07:29 - TeleTrader - Siemens Healthineers jumps up to 5.3% in IPO
03/16/2018 / 10:30 - TeleTrader - RWE shifts to profit of €1.9B last year
03/13/2018 / 07:27 - TeleTrader - Europe closes mixed as utilities soar
03/12/2018 / 17:33 - TeleTrader - Europe starts in green on back of US jobs report
03/12/2018 / 09:08 - TeleTrader - New Data from Pivotal Phase 3 Study Investigating Lanadelumab as a Prophylactic Treatment for HAE to be Presented at 2018 AAAAI/WAO Joint Congress
03/03/2018 / 15:46 - GlobeNewswire - CORRECTION - Shire Announces FDA Acceptance of sBLA for CINRYZE® for Pediatric Hereditary Angioedema Use
02/15/2018 / 14:13 - GlobeNewswire - Shire Announces FDA Acceptance of sBLA for CINRYZE® for Pediatric Hereditary Angioedema Use
02/15/2018 / 13:01 - GlobeNewswire
Real-time